CYCLON and NPM1 Cooperate within an Oncogenic Network Predictive of R-CHOP Response in DLBCL.
Saved in:
| Title: | CYCLON and NPM1 Cooperate within an Oncogenic Network Predictive of R-CHOP Response in DLBCL. |
|---|---|
| Authors: | Bouroumeau A; Department of Pathology, Grenoble-Alpes University Hospital, 38000 Grenoble, France.; Translational Epigenetics, Institute for Advanced Biosciences, INSERM U1209, CNRS UMR 5309, Grenoble-Alpes University, 38000 Grenoble, France.; Division of Clinical Pathology, Diagnostic Department, Hôpitaux Universitaires Genève, 1205 Geneva, Switzerland., Bussot L; Translational Epigenetics, Institute for Advanced Biosciences, INSERM U1209, CNRS UMR 5309, Grenoble-Alpes University, 38000 Grenoble, France.; Department of Clinical Hematology, Grenoble-Alpes University Hospital, 38000 Grenoble, France., Hamaidia S; Translational Epigenetics, Institute for Advanced Biosciences, INSERM U1209, CNRS UMR 5309, Grenoble-Alpes University, 38000 Grenoble, France.; Pole Recherche, Grenoble-Alpes University Hospital, 38000 Grenoble, France., Garcìa-Sandoval A; Translational Epigenetics, Institute for Advanced Biosciences, INSERM U1209, CNRS UMR 5309, Grenoble-Alpes University, 38000 Grenoble, France.; Pole Recherche, Grenoble-Alpes University Hospital, 38000 Grenoble, France., Bergan-Dahl A; Translational Epigenetics, Institute for Advanced Biosciences, INSERM U1209, CNRS UMR 5309, Grenoble-Alpes University, 38000 Grenoble, France., Betton-Fraisse P; Translational Epigenetics, Institute for Advanced Biosciences, INSERM U1209, CNRS UMR 5309, Grenoble-Alpes University, 38000 Grenoble, France., Duley S; Translational Epigenetics, Institute for Advanced Biosciences, INSERM U1209, CNRS UMR 5309, Grenoble-Alpes University, 38000 Grenoble, France., Fournier C; Unit for Innovation in Genetics and Epigenetics in Oncology and Dijon University Hospital, University of Bourgogne, INSERM 1231, 21000 Dijon, France., Aucagne R; Unit for Innovation in Genetics and Epigenetics in Oncology and Dijon University Hospital, University of Bourgogne, INSERM 1231, 21000 Dijon, France., Adrait A; Institut National de la Santé et de la Recherche Médicale (INSERM), University Grenoble Alpes, CEA, UMR BioSanté U1292, CNRS, CEA, FR2048, 38000 Grenoble, France., Couté Y; Institut National de la Santé et de la Recherche Médicale (INSERM), University Grenoble Alpes, CEA, UMR BioSanté U1292, CNRS, CEA, FR2048, 38000 Grenoble, France., McLeer A; Department of Pathology, Grenoble-Alpes University Hospital, 38000 Grenoble, France., Col E; Department of Pathology, Grenoble-Alpes University Hospital, 38000 Grenoble, France., David-Boudet L; Department of Pathology, Grenoble-Alpes University Hospital, 38000 Grenoble, France., Raskovalova T; Hematology, Oncogenetics and Immunology Unit, Grenoble-Alpes University Hospital, 38000 Grenoble, France., Jacob MC; Hematology, Oncogenetics and Immunology Unit, Grenoble-Alpes University Hospital, 38000 Grenoble, France., Vettier C; Hematology, Oncogenetics and Immunology Unit, Grenoble-Alpes University Hospital, 38000 Grenoble, France., Chevalier S; Hematology, Oncogenetics and Immunology Unit, Grenoble-Alpes University Hospital, 38000 Grenoble, France., Carras S; Translational Epigenetics, Institute for Advanced Biosciences, INSERM U1209, CNRS UMR 5309, Grenoble-Alpes University, 38000 Grenoble, France.; Department of Clinical Hematology, Grenoble-Alpes University Hospital, 38000 Grenoble, France.; Hematology, Oncogenetics and Immunology Unit, Grenoble-Alpes University Hospital, 38000 Grenoble, France., Lefebvre C; Translational Epigenetics, Institute for Advanced Biosciences, INSERM U1209, CNRS UMR 5309, Grenoble-Alpes University, 38000 Grenoble, France.; Hematology, Oncogenetics and Immunology Unit, Grenoble-Alpes University Hospital, 38000 Grenoble, France., Algrin C; Daniel Hollard Institute, 38000 Grenoble, France., Gressin R; Translational Epigenetics, Institute for Advanced Biosciences, INSERM U1209, CNRS UMR 5309, Grenoble-Alpes University, 38000 Grenoble, France.; Department of Clinical Hematology, Grenoble-Alpes University Hospital, 38000 Grenoble, France., Callanan MB; Unit for Innovation in Genetics and Epigenetics in Oncology and Dijon University Hospital, University of Bourgogne, INSERM 1231, 21000 Dijon, France., Sartelet H; Department of Pathology, Grenoble-Alpes University Hospital, 38000 Grenoble, France.; Department of Pathology, Nancy Regional University Hospital, 54000 Nancy, France., Bonnefoix T; Translational Epigenetics, Institute for Advanced Biosciences, INSERM U1209, CNRS UMR 5309, Grenoble-Alpes University, 38000 Grenoble, France.; Pole Recherche, Grenoble-Alpes University Hospital, 38000 Grenoble, France., Emadali A; Translational Epigenetics, Institute for Advanced Biosciences, INSERM U1209, CNRS UMR 5309, Grenoble-Alpes University, 38000 Grenoble, France.; Pole Recherche, Grenoble-Alpes University Hospital, 38000 Grenoble, France. |
| Source: | Cancers [Cancers (Basel)] 2021 Nov 24; Vol. 13 (23). Date of Electronic Publication: 2021 Nov 24. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
